Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in NSTEMI with elevated NT-proBNP
NCT03189901Phase 4Unknown
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jul 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in non-ST segment elevation myocardial infarction (NSTEMI), sponsored by Qilu Hospital of Shandong University. Status: unknown.
02
Drugs
levosimendan
03
Conditions
non-ST segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT03189901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03189901.